AnalystsFaisal Khurshid
Faisal Khurshid's Stock Forecasts

Analyst Ranking
Bottom 8%
#4532 out of 4923 analysts
Average Return
-22.24%
Win Rate
36%5 out of 14
Risk vs Reward
Poor
Good

Faisal Khurshid's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Trevi Therapeutics IncTRVI
+75.32%$3.12$5.47
2024-09-09 -
2025-06-30
Buy
Atyr Pharma IncATYR
+33.77%$3.79$5.07
2025-02-18 -
2025-06-30
Buy
Spyre Therapeutics IncSYRE
+26.86%$11.80$14.97
2025-04-08 -
2025-06-30
Buy
Ani Pharmaceuticals IncANIP
+10.28%$59.17$65.25
2024-12-11 -
2025-06-30
Buy
Kymera Therapeutics IncKYMR
+8.80%$40.11$43.64
2024-12-27 -
2025-06-30
Buy

Faisal Khurshid Analyst Color

Get additional color on Faisal Khurshid's coverage of popular stocks

Faisal Khurshid's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ironwood Pharmaceuticals IncIRWD
2Hold$1.00+39.47%Maintains
3 months ago
Spyre Therapeutics IncSYRE
1Buy$45.00+200.60%Initiates Coverage On
3 months ago
Nurix Therapeutics IncNRIX
1Hold$16.00+40.47%Initiates Coverage On
3 months ago
Shattuck Labs IncSTTK
1Buy$4.00+405.05%Initiates Coverage On
3 months ago
Pliant Therapeutics IncPLRX
2Hold$2.00+72.41%Downgrades
4 months ago
Atyr Pharma IncATYR
1Buy$16.00+215.58%Initiates Coverage On
4 months ago
Kymera Therapeutics IncKYMR
2Buy$60.00+37.49%Maintains
6 months ago
Ani Pharmaceuticals IncANIP
1Buy$80.00+22.61%Initiates Coverage On
7 months ago
Zura Bio LtdZURA
1Buy$15.00+1,328.57%Initiates Coverage On
8 months ago
Trevi Therapeutics IncTRVI
1Buy$7.00+27.97%Assumes
10 months ago
Puretech Health PLCPRTC
1Buy$45.00+160.87%Assumes
10 months ago
Galapagos NvGLPG
1Hold$24.00-14.26%Initiates Coverage On
10 months ago
Geron CorpGERN
1Buy$7.00+396.45%Initiates Coverage On
10 months ago
Mannkind CorpMNKD
1Buy$8.00+113.90%Assumes
10 months ago
Immunic IncIMUX
1Buy$5.00+616.33%Assumes
10 months ago
Fusion Pharmaceuticals IncFUSN
1Hold$21.00N/ADowngrades
a year ago
Rain Oncology IncRAIN2
1Buy$11.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.